Scott Tarriff Eagle Pharmaceuticals, Inc. (EGRX) insider trading activity

EGRX Quotes by TradingView

Scott Tarriff is of EAGLE PHARMACEUTICALS, INC.. Currently has a direct ownership of 460,621 shares of EGRX, which is worth approximately $230,310. The most recent transaction as insider was on Feb 28, 2024, when has been sold 2,119 shares (Common Stock) at a price of $6.27 per share, resulting in proceeds of $13,286. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 461K
0% 3M change
15.55% 12M change
Total Value Held $230,310

Scott Tarriff Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 28 2024
SELL
Payment of exercise price or tax liability
$13,286 $6.27 p/Share
2,119 Reduced 0.46%
460,621 Common Stock
Feb 27 2024
SELL
Payment of exercise price or tax liability
$20,311 $6.44 p/Share
3,154 Reduced 0.68%
462,740 Common Stock
Feb 27 2024
BUY
Grant, award, or other acquisition
-
12,950 Added 2.7%
465,894 Common Stock
Jan 05 2024
SELL
Payment of exercise price or tax liability
$22,171 $5.13 p/Share
4,322 Reduced 0.79%
541,125 Common Stock
Nov 02 2023
SELL
Open market or private sale
$148,325 $13.87 p/Share
10,694 Reduced 1.92%
545,447 Common Stock
Nov 01 2023
SELL
Open market or private sale
$150,983 $13.82 p/Share
10,925 Reduced 1.93%
556,141 Common Stock
Oct 03 2023
SELL
Open market or private sale
$158,433 $14.76 p/Share
10,734 Reduced 1.86%
567,066 Common Stock
Oct 02 2023
SELL
Open market or private sale
$144,852 $15.23 p/Share
9,511 Reduced 1.62%
577,800 Common Stock
May 16 2023
SELL
Open market or private sale
$299,700 $19.98 p/Share
15,000 Reduced 2.49%
587,311 Common Stock
May 15 2023
SELL
Open market or private sale
$319,350 $21.29 p/Share
15,000 Reduced 0.93%
1,594,934 Common Stock
May 12 2023
SELL
Open market or private sale
$300,900 $20.06 p/Share
15,000 Reduced 0.92%
1,609,934 Common Stock
May 11 2023
SELL
Open market or private sale
$310,650 $20.71 p/Share
15,000 Reduced 0.91%
1,624,934 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
70,900 Added 4.14%
1,639,934 Common Stock
Feb 28 2023
SELL
Payment of exercise price or tax liability
$87,164 $28.0 p/Share
3,113 Reduced 0.2%
1,569,034 Common Stock
Jan 23 2023
SELL
Payment of exercise price or tax liability
$125,544 $33.64 p/Share
3,732 Reduced 0.24%
1,572,147 Common Stock
Jan 05 2023
SELL
Payment of exercise price or tax liability
$111,978 $29.26 p/Share
3,827 Reduced 0.24%
1,575,879 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
-
34,800 Added 2.16%
1,579,706 Common Stock
Apr 01 2021
SELL
Payment of exercise price or tax liability
$681,560 $41.87 p/Share
16,278 Reduced 1.04%
1,544,906 Common Stock
Apr 01 2021
BUY
Exercise of conversion of derivative security
$273,945 $8.78 p/Share
31,201 Added 1.96%
1,561,184 Common Stock
Feb 23 2021
SELL
Bona fide gift
-
16,340 Reduced 1.06%
1,529,983 Common Stock
Jan 23 2021
SELL
Payment of exercise price or tax liability
$220,899 $47.7 p/Share
4,631 Reduced 0.3%
1,546,323 Common Stock
ST

Scott Tarriff

Woodcliff Lake, NJ

Track Institutional and Insider Activities on EGRX

Follow EAGLE PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EGRX shares.

Notify only if

Insider Trading

Get notified when an Eagle Pharmaceuticals, Inc. insider buys or sells EGRX shares.

Notify only if

News

Receive news related to EAGLE PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EGRX